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Abstract 
Background: Human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) are leading causes of viral 
severe acute respiratory illnesses in childhood. Both the two viruses belong to the Pneumoviridae family and show 
overlapping clinical, epidemiological and transmission features. However, it is unknown whether these two viruses 
have similar geographic spread patterns which may inform designing and evaluating their epidemic control 
measures.
Methods: We conducted comparative phylogenetic and phylogeographic analyses to explore the spatial-temporal 
patterns of HMPV and RSV across Africa using 232 HMPV and 842 RSV attachment (G) glycoprotein gene sequences 
obtained from 5 countries (The Gambia, Zambia, Mali, South Africa, and Kenya) between August 2011 and January 
2014.
Results: Phylogeographic analyses found frequently similar patterns of spread of RSV and HMPV. Viral sequences 
commonly clustered by region, i.e., West Africa (Mali, Gambia), East Africa (Kenya) and Southern Africa (Zambia, South 
Africa), and similar genotype dominance patterns were observed between neighbouring countries. Both HMPV and 
RSV country epidemics were characterized by co-circulation of multiple genotypes. Sequences from different African 
sub-regions (East, West and Southern Africa) fell into separate clusters interspersed with sequences from other coun-
tries globally.
Conclusion: The spatial clustering patterns of viral sequences and genotype dominance patterns observed in our 
analysis suggests strong regional links and predominant local transmission. The geographical clustering further 
suggests independent introduction of HMPV and RSV variants in Africa from the global pool, and local regional 
diversification.
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Introduction
Human metapneumovirus (HMPV) and respiratory syn-
cytial virus (RSV) are leading viral respiratory pathogens 
that cause seasonal epidemics of acute respiratory tract 
illness and are responsible for a significant fraction of 
childhood pneumonia [1]. A multi-country study named 
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PERCH (Pneumonia Etiology Research for Child Health), 
undertaken between 2011 and 2014 in Africa and Asia 
reported RSV as the leading cause of pneumonia in chil-
dren aged under five years accounting for at least 31% 
of the aetiological distribution [2]. In the same study, 
HMPV accounted for 5% of the aetiological distribution. 
The current study presents a molecular-epidemiological 
analysis of samples collected by the PERCH study from 
the five African counties, i.e., Kenya, South Africa, Zam-
bia, Mali and The Gambia.
RSV and HMPV infections present with overlapping 
clinical and epidemiological profiles [3, 4]. Following 
infection with either virus, the clinical presentation can 
range from asymptomatic infection to mild upper res-
piratory tract illness to severe lower respiratory tract 
disease. Further, these clinical features are also observed 
with several other respiratory viruses e.g. influenza and 
human coronaviruses [3, 5]. Both HMPV and RSV infect 
persons across all ages but severe disease is majorly lim-
ited to infants and young children, the vulnerable adult 
populations (the elderly, immunocompromised and 
persons with cardiopulmonary co-morbidities) [4, 6, 
7]. Re-infection with these viruses occurs throughout 
life probably due to incomplete immunity that wanes 
over time combined with ongoing antigenic variation 
in key viral immune epitopes which may support anti-
body escape [8, 9]. RSV and HMPV seasonal patterns 
are observed to frequently overlap. In temperate climatic 
regions they tend to peak in cold seasons while in the 
tropics the association of peak transmission months and 
weather patterns has been inconsistent [10]. Transmis-
sion of these two viruses is primarily via direct inhalation 
of infected droplets or indirect via fomites (contaminated 
objects or surfaces) contacts [11–13].
The two viruses belong to Pneumoviridae family and 
share several genomic features [14]. HMPV genome is 
about 13  kb encoding eight genes (3′N–P–M–F–M2–
SH–G–L5′) while RSV genome is about 15  kb encod-
ing ten genes (3′NS1-NS2-N-P-M-SH-G-F-M2-L5) 
thus HMPV has a different gene order and lacks non-
structural proteins NS1 and NS2 [14]. For both RSV and 
HMPV, the attachment glycoprotein (G) gene is the most 
genetically variable region across their entire genomes 
and is commonly used to discriminate genetic variants 
[15, 16]. HMPV is classified into two groups, A and B, 
based on antigenic and genetic differences mainly in the 
fusion (F) and attachment (G) glycoprotein genes [16]. 
Based on the genetic differences, the two groups are fur-
ther classified into four subgroups, A1, A2 (group A) and 
B1 and B2 (group B) [16]. Subgroup A2 is the most genet-
ically diverse and is further divided into sub-lineages 
A2a and A2b [17, 18]. Additionally, there are two distinct 
clades within A2b, A2b1 and A2b2 [18].Similarly, RSV is 
classified into two groups (A and B) that are both anti-
genically and genetically distinct [19]. The two groups are 
further divided into multiple genotypes based on nucleo-
tide differences within the RSV G gene [20]. Clinically, 
there is no difference in disease severity between the sub-
groups for both HMPV and RSV [5, 21]. Epidemiological 
studies have shown that multiple HMPV and RSV sub-
type/genotypes can co-circulate during epidemics both 
locally and globally, implying fast and widespread dis-
persal HMPV and RSV variants once they arise [22, 23]. 
The dominant subgroup/genotype can also vary based on 
year and location [15, 23].
It is unclear whether HMPV and RSV share geographic 
spread patterns. Although this can be investigated using 
sequence and spatial-temporal data, such data is scarce 
and there is asynchronous sampling in time and space, 
especially in Africa [24]. As a result, the origins and 
interconnectedness of RSV and HMPV epidemics across 
many global locations including Africa is not well under-
stood. Integrating pathogen sequence data with other 
data e.g. spatial-temporal data allows reconstruction of 
transmission histories necessary for tracing of epidemio-
logical linkages especially when there is limited case sur-
veillance and tracing [25, 26]. Both HMPV and RSV are 
undergoing continuous genetic sequence evolution lead-
ing to occasional emergence of novel genotypes [27–29] 
thus understanding their geographic spread could help 
inform interventions in future epidemics. Here, we report 
comparative phylogenetic analysis of HMPV and RSV 
sequence data collected between 2011–2014 across five 
African countries (Kenya, Mali, Gambia, South Africa 
and Zambia) located in different sub-regions (East, West 
and South). Our study provides an initial view of RSV 
and HMPV phylogeography across Africa detailing their 
overall spatial-temporal transmission patterns within the 
continent in relation to the rest of the world.
Materials and methods
Study samples
The study analyzed nasopharyngeal (NP) flocked swab or 
a combination of nasopharyngeal swab and oropharyn-
geal (OP) swabs positive for HMPV and RSV. The sam-
ples were identified during the PERCH study [2, 30, 31] 
conducted between August 2011 and January 2014 from 
5 African countries (The Gambia, Zambia, Mali, South 
Africa and Kenya), Table 1 and Additional file 1. A sin-
gle hospital site, backed by well-defined catchment areas 
of known population size, was selected in each country 
[30]. Site characteristics for each country are reported in 
[30, 31]. Cases (hospital admissions) and controls (per-
sons attending outpatient facilities for mild illness or 
vaccination) were selected within the defined catchment 
areas. Cases included children aged between 28  days 
Page 3 of 13Oketch et al. Virol J          (2021) 18:104  
and 59  months with severe or very severe pneumonia 
[30, 31]. Controls were randomly enrolled regardless of 
the respiratory symptoms and matched to cases by loca-
tion and age group (1 to < 6 months, 6 to < 12 months, 12 
to < 24 months, and 24–59 months of age) [2, 31]. Writ-
ten informed consent was obtained from the parent or a 
guardian of the enrolled children.
The present study was approved by the Scientific 
and Ethical Review Unit that sits at KEMRI in Nairobi 
(SERU# 3443) and the PERCH Committee (http:// www. 
jhsph. edu/ ivac/ resou rces/ perch- backg round- and- metho 
ds/).
Laboratory methods
Viral RNA was extracted using QIAamp Viral RNA 
Minikit (Qiagen, Germany) following the manufac-
turer’s instructions. Reverse transcription and PCR 
amplification of the HMPV and RSV G genes followed 
protocols that have been reported elsewhere [23, 32]. 
Briefly, HMPV PCR primers amplified full G gene, 
approximately 700  bp in a one-step reverse transcrip-
tion (RT) PCR using Qiagen kit. HMPV subgroup spe-
cific primers were used (Additional file 2) and have been 
reported in [23]. Thermocycling conditions were set 
at: 50 °C for 30 min, 95 °C for 15 min, 38cycles of 94 °C 
for 1  min, 53  °C for 1  min, 72  °C for 1  min, and a final 
extension of 10  min at 72  °C [23]. For RSV, a two-step 
PCR protocol was employed. The first-round amplifica-
tion was performed using Qiagen one-step RT-PCR kit, 
and the second-round nested PCR performed using Qia-
gen TaqMan PCR kit mastermix. Thermocycling condi-
tions and primers used have been reported elsewhere 
[32] RSV cross-group primers were used in both first and 
second-round PCR steps, and subgroup specific prim-
ers included in sequencing (Additional file 2). Amplified 
fragments were sequenced in both forward and reverse 
strands using the BigDye Terminator v1.3 chemistry 
on ABI 3130xl. The sequenced contigs were assembled 
using Sequencher v5.4.6 (Gene Codes Corporation). For 
Kenyan samples, the sequences have been previously 
reported in different studies under the accession num-
bers listed in Additional File 3. For The Gambia, Mali, 
South Africa and Zambia the sequences are reported in 
this study under the accession numbers shown in Addi-
tional file  3 for each country. The GenBank accession 
numbers of the contemporaneous sequences analysed in 
this study are also listed in Additional file 3.
Sequence analysis
Sequences were aligned using MAFFT v7.407 [33] and 
manually curated in AliView v1.26 [34]. Pairwise genetic 
distances were calculated in MEGA v7. 0.2. software [35] 
under the Maximum Composite Likelihood method to 
Table 1 Virus positive by site and number sequenced
Total number of HMPV and RSV positive samples collected between August 2011 and January 2014 from 5 African countries. Panel A: Total number of HMPV 
sequences stratified by cases and controls, and total sequenced. Panel B: Total number of RSV sequences stratified by cases and controls, and total sequenced
HMPV, human metapneumovirus; RSV, respiratory syncytial virus
Site Enrollment date No. of samples Cases Controls Total 
sequenced
No. of cases No. sequenced No. of controls No. sequenced
(A) HMPV
Gambia November 2011–October 2013 46 37 32 9 9 41
Kenya August 2011–November 2013 62 50 50 13 8 58
Mali January 2012–January 2014 46 39 34 7 6 40
South Africa August 2011–August 2013 77 55 44 22 14 58
Zambia October 2011–October 2013 47 39 30 8 5 35
Totals 278 200 190 59 42 232
Site Enrollment date No. of samples Cases Controls Total 
sequenced
No. of cases No. sequenced No. of controls No. sequenced
(B) RSV
Gambia November 2011–October 2013 117 113 97 4 2 99
Kenya August 2011–November 2013 263 251 251 12 12 263
Mali January 2012–January 2014 182 154 138 28 20 158
South Africa August 2011–August 2013 260 232 208 28 22 230
Zambia October 2011–October 2013 112 94 82 18 10 92
Totals 934 844 776 90 66 842
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assess the genetic diversity between sequences within the 
groups.
Phylogenetic and phylogeographic analysis
The best fitting nucleotide substitution and site hetero-
geneity models were determined using ModelFinder [36] 
in IQ-TREE v1.6.11 [37]. Phylogenetic trees were con-
structed using the Maximum Likelihood (ML) approach 
in IQ-TREE v1.6.11. Branch support was evaluated by 
bootstrapping. HMPV and RSV subgroups/genotypes 
were confirmed if sequences clustered with known 
subgroups or prototype sequences of HMPV and RSV 
retrieved from GenBank (Additional file 3).
Phylogeographic analyses were done in BEAST v1.10.4 
[38]. First, preliminary analysis was done to test for tem-
poral signal and to identify the best coalescent demo-
graphic model. The temporal signal in the sequence 
data i.e. a root-to-tip divergence of genetic distance 
against the year of sampling was assessed using Tem-
pEst software v1.5.3 [39]. Four coalescent tree priors i.e. 
constant population size, exponential growth, Bayes-
ian skyline plot and Bayesian Gaussian Markov Random 
Field (GMRF) skyride plot were tested under an uncor-
related lognormal relaxed molecular clock, and path 
sampling and stepping-stone analyses carried out to 
estimate marginal likelihoods [40]. The marginal likeli-
hood measures the average fit of a model to the data [38]. 
Lower marginal likelihoods indicated weak evidence 
against the competing model. The Markov Chain Monte 
Carlo (MCMC) chains convergence [effective sample 
size (ESS) > 200] were evaluated in TRACER v1.7.1 [41]. 
The best combination of uncorrelated lognormal relaxed 
molecular and demographic models was selected for sub-
sequent analysis.
A discrete trait representing geographical location was 
assigned to each sequence: Western Africa (Mali, Gam-
bia), Eastern Africa (Kenya) and Southern Africa (South 
Africa and Zambia). To attain high spatial resolution, 
the country of sampling was also assigned to sequences. 
Viral dispersal patterns between locations were inferred 
using the Bayesian symmetric discrete trait evolution 
model with Bayesian stochastic search variable selec-
tion (BSSVS) procedure, implemented in BEAST v1.10.4. 
software. The symmetric diffusion model infers ances-
tral reconstruction using the standard continuous-time 
Markov chain (CTMC), in which the transition rates 
between locations are reversible [25]. MCMC chains 
were run for at least 200 million generations sampling 
every 20,000 steps.
Contemporaneous sequences with known collection 
date were retrieved from GenBank (Additional file 3) for 
global phylogeographic analysis. Due to the scarcity of 
HMPV G gene sequences, 714 sequences collected from 
20 countries between 2000 and 2018 were included. For 
RSV, sequences collected a year before (2010) and after 
(2015) our study were analysed to place our data into 
immediate context. A total of 1810 sequences from 28 
different countries were retrieved (Additional file 3). Both 
the continent and the country of sampling were assigned 
sequences as discrete traits. The global phylogeographic 
analysis was carried out under the symmetric diffusion 
model. The BEAST trees were summarised using Tree 
annotator v2.6.0 [42] after the removal of 10% burn-in. 
Maximum clade credibility trees (MCC) were visual-
ized in FigTree v1.4.4. (http:// tree. bio. ed. ac. uk/ softw are/ 
figtr ee/). Significant migration events between discrete 
locations were determined using the Bayes factor (BF) 
[40] and summarized using SpreaD3 v0.9.7.1 software 
[43] after discarding 10% burn-in. BF ≥ 1000 indicated 
very strong support, 10 ≤ BF ≤ 1000 strong support, and 
3 ≤ BF ≤ 10 supported viral migration pathways.
Results
HMPV and RSV subgroup detection and temporal patterns
In total, 232 HMPV G gene sequences were obtained of 
which 44% (102/232) belonged to subgroup A2 and fur-
ther clustered into sub-lineages A2.1 (18%, 18/102) and 
A2.2 (82%, 84/102) (Additional file  4). Sub-lineage A2.2 
further clustered into two distinct clades, A2.2.1 (35/84) 
and A2.2.2 (49/84) (Additional file 4). There were no sub-
group A1 viruses. Among the sequenced HPMV strains, 
56% (130/232) belonged to HMPV group B, of which 82% 
(107/130) and 18% (23/130) were subgroup B1 and B2, 
respectively. Multiple subgroups co-circulated in each 
country (Fig. 1a). Notably, A2.1 viruses were only identi-
fied in South Africa and Zambia. HMPV subgroup tem-
poral patterns in Mali mirrored those in The Gambia 
(Fig. 1a). For RSV, a total of 842 sequences were analysed. 
Based on the RSV G gene phylogeny (Additional file 4), 
there were 509/842 (60%) RSVA and 333/842 (40%) 
RSVB sequences. All RSV B sequences belonged to the 
genotype BA. Among RSV A, 32% (163/509) were geno-
type ON1, and 68% (346/509) were genotype GA2. Simi-
lar to HMPV, multiple RSV genetic groups co-circulated 
within epidemics (Fig. 1b). Similar genotype dominance 
patterns were observed between Mali and Gambia, South 
Africa and Zambia, and were all different from Kenya 
(Fig. 1b).
HMPV Intra‑country genetic diversity
Only subgroup B1 viruses were detected in high fre-
quencies in all the five countries and were analysed 
for intra-country diversity (Table  2). ML trees were 
reconstructed independently for each country. At least 
two well supported (bootstrap value > 95%) phyloge-
netic clades were observed in each country (Additional 
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file  5). Sequences from different within-country sam-
pling locations were mixed within the phylogenetic 
clusters suggesting rapid spread of HMPV variants 
within each country. Sequences from cases and con-
trols were mixed within the clades (Additional file 5).
HMPV spatial origins and dispersal patterns in Africa
B1 sequences clustered into two major phylogenetic 
clades, numbered B1.1 and B1.2 (Fig. 2a). Sequences from 
the same geographical region, i.e. West Africa (Mali and 
Gambia), East Africa (Kenya) and Southern Africa (South 
Fig. 1 HMPV and RSV subgroup prevalence and temporal patterns derived from G gene sequence data collected from Kenya, Mali, Gambia, South 
Africa and Zambia. a HMPV temporal patterns. b RSV temporal patterns
Table 2 HMPV and RSV subgroup detection patterns
Total number of HMPV and RSV sequences obtained from samples collected between August 2011 and January 2014 from the 5 African countries. Panel A: Total 
number of HMPV sequences obtained by HMPV subgroup for each study site. Panel B: Total number of RSV sequences obtained by RSV subgroup for each study site
HMPV, human metapneumovirus; RSV, respiratory syncytial virus
Country A2.1 A2.2 B1 B2 Total
(A) HMPV subgroup detection
Kenya 0 21 21 16 58
Gambia 0 12 27 2 41
Mali 0 8 32 0 40
South Africa 6 33 15 4 58
Zambia 12 10 12 1 35
Total 18 84 107 23 232
Country RSVA_ON1 RSVA_GA2 RSVB_BA Total
(B) RSV subgroup detection
Kenya 114 42 107 263
Gambia 2 8 89 99
Mali 5 47 106 158
South Africa 13 188 29 230
Zambia 29 61 2 92
Total 163 346 333 842
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Africa and Zambia) closely clustered together (Fig.  2a). 
On the global MCC tree the two clades (B2.1 and B2.2) 
were placed into two major clades alongside global 
sequences, suggesting that at least two distinct B1 vari-
ants were in circulation (Fig. 2b). The two variants reflect 
the genetic clusters that were observed on country-spe-
cific ML phylogenies above (Additional file 5). Clade B1.1 
clustered closely with sequences from Nepal, and a few 
from Croatia and Spain. Clade B2.2 clustered closely with 
sequences from Malaysia. Although B1 sequences from 
Africa were interspersed with global sequences, they 
mostly clustered together. Of note, 81% (178/228) of B1 
sequences were from Africa and Asia, making it difficult 
to assess viral introductions from unsampled locations.
Consistent with B1 MCC phylogenies of A2.2 and 
B2 African sequences showed at least two circulat-
ing variants for each subgroup (Fig.  3). Sequences from 
South Africa and Zambia clustered together. Similarly, 
sequences from Gambia and Mali clustered more closely 
among themselves, indicating an epidemiological linkage 
between neighbouring countries and separate introduc-
tions of HMPV variants in Africa. For A2.2, sequences 
clustered into two major clades numbered A2.2.1 and 
A2.2.2 (Fig.  3a). Similarly, B2 viruses clustered at least 
into two major clades, B2.1 and B2.2 (Fig. 3b). Clade B2.2 
was predominantly made of Kenyan sequences. On the 
global phylogenies (Fig. 4), the major clades observed in 
A2.2 and B2 clustered separately interspersed with global 
sequences, suggesting that at least two distinct variants 
for each subgroup were in circulation. (Fig.  4). Within 
the clades, the African sequences fell into separate clus-
ters. The most probable location of ancestral sequence at 
the branches leading to each African clade is indicated 
next to the nodes for each clade (Fig. 4). The commonly 
inferred locations included sequences sampled from 
Malaysia, Peru, Canada and Spain. For A2.1 viruses, Afri-
can sequences were placed into a single monophyletic 
clade indicating a single introduction (Additional file 6). 
Notably, A2.1 sequences were only detected in Zambia 
and South Africa and clustered closely with sequences 
from Peru.
RSV intra country diversity
To assess within-country genetic diversity, Only RSV 
BA and GA2 viruses were detected in high frequencies 
across multiple sites and were analysed (Table  2). From 
the country-specific ML phylogenies, sequences from 
the different within-country sampling locations were 
Fig. 2 Time-scaled maximum clade credibility (MCC) trees of HMPV B1 G gene sequences. a Phylogenetic tree of B1 sequences obtained from 
Africa collected between August 2011 to January 2014. Tip shapes are coloured by country of sampling. b Phylogeny of HMPV B1 G gene 
sequences obtained from Africa and GenBank collected between 2000 to 2018. Tree tips are coloured by country of sampling. Geographic locations 
considered are shown in the figure key. Any sequences from Kenya, Mali, Gambia, South Africa and Zambia obtained from GenBank and collected 
beyond the study period are indicated with a suffix gb. Clades containing African sequences were labelled to reflect genetic clusters observed on 
the continental (Africa) B1 phylogeny—highlighted by grey vertical bars. African sequences are also indicated with tip labels. The most probable 
location of ancestral sequence at the branches leading to each African monophyletic clade is shown next to the nodes. Only ancestral locations 
with posterior probability support of > 70% were indicated
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Fig. 3 Time-scaled maximum clade credibility (MCC) trees constructed using HMPV A2.2 (a) and HMPV B2 (b) G gene sequences obtained from 
Africa, collected between August 2011 and January 2014. Tip shapes are coloured by country of sampling
Fig. 4 Time-scaled maximum clade credibility (MCC) trees constructed using HMPV A2.2 (a) and HMPV B2 (b) G gene sequences obtained from 
Africa and GenBank, collected between 2000 to 2018. Tree tips are coloured by country of sampling. Geographic locations considered are shown in 
the figure key. Any sequences from Kenya, Mali, Gambia, South Africa and Zambia obtained from GenBank and collected beyond the study period 
are indicated with a suffix _gb. African sequences are indicated with tip labels. The most probable location of ancestral sequence at the branches 
leading to each African monophyletic clade is shown next to the nodes. Only ancestral locations with posterior probability support of > 70% were 
indicated
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mixed within the phylogenetic clusters suggesting rapid 
spread movement of RSV variants within each country 
(Additional file 7). Similarly, the RSV G gene sequences 
did not cluster by case or control status of the sampled 
individuals.
RSV spatial patterns and Origins in Africa
RSV phylogeographic analysis revealed markedly similar 
spatial patterns to those of HMPV. On the continental 
scale (Africa), geographical clustering was evident, and 
multiple variants of each RSV genotype were detected 
(Fig.  5). The inferred continental migration pathways 
indicated very strongly supported links between neigh-
bouring countries (BF > 1000, posterior probability > 95%) 
i.e., between The Gambia and Mali, and between South 
Africa and Zambia (Additional file  8). We further 
explored the RSV spatial patterns globally to elucidate 
on the viral introductions into Africa. African ON1 
sequences fell into two major clades (numbered ON1.1 
and ON1.2, Fig.  6) interspersed with global sequences. 
Although the clades ON1.1 and ON1.2 were inter-
spersed with global sequences, high sequence similarity 
(99%) was observed among them indicating widespread 
movement of similar variants globally. Of the two Afri-
can clades (Fig.  6), clade ON1.1 clustered closely with 
sequences from Europe (Spain and Russia) and Asia 
(India and Jordan). Clade ON1.2 sequences clustered 
closely to sequences from USA. Similar to ON1, GA2 and 
BA African sequences were placed into multiple clades 
alongside global sequences (Additional file 9). Within the 
clades, GA2 and BA African sequences were interspersed 
with sequences sampled from different countries globally. 
Majority of GA2 and BA African sequences clustered 
with sequences from Thailand, Peru, China, USA, and 
b : RSV_BA









a : RSV GA2
2007 2008 2009 2010 2011 2012 2013 2014 2012 2012.5 2013 2013.5 2014
Fig. 5 Time-scaled maximum clade credibility trees constructed using RSV GA2 (a), BA (b) and ON1 (c) G gene sequences obtained from Kenya, 
Mali, Gambia, South Africa and Zambia collected between August 2011 and January 2014. The tips were coloured according to the country of 
sampling
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Spain. Locations of ancestral sequences at the branches 
leading to each African clade with posterior probability 
support of > 70% are indicated along the nodes on the 
phylogenies (Additional file 9).
Discussion
Our comparative analysis revealed markedly similar pat-
terns of spread of HMPV and RSV within Africa. Geo-
graphical clustering of sequences by sub-region was 
evident with high sequence relatedness between neigh-
bouring countries and separate variant introductions of 
HMPV and RSV into continental Africa. This observation 
indicates predominant local transmission and frequently 
common sources of introduction among neighbouring 
countries. Within each country, sequences from the dif-
ferent catchment areas were mixed within the phyloge-
netic clusters, suggesting a rapid movement of HMPV 
and RSV variants within country upon variant introduc-
tion followed by local diversification. However, we can-
not ignore the fact that only a single site was sampled in 
each country. Therefore, we may not have characterised 
all locally circulating strains. At least two distinct vari-
ants of the various genetic groups were observed in each 
country, indicating multiple importations from the global 
pool. These results are not unique to only HMPV and 
RSV as similar findings have been reported for influenza 
viruses and more recently for SARS-CoV-2 transmission 
in Kenya, Uganda and South Africa [44–46].
HMPV and RSV epidemics were characterised by co-
circulation of multiple genotypes. Genotype circulation 
patterns were similar between neighboring African coun-
tries (South Africa and Zambia, and Mali and The Gam-
bia), indicative of the epidemiological linkage between 

































































































































































Tip shape colour =country
Fig. 6 Time-scaled maximum clade credibility tree constructed using RSV ON1 G gene sequences obtained from Africa and GenBank collected 
between 2010 to 2015. Tree tips are coloured by country of sampling. Geographic locations considered are shown in the figure key. Any sequences 
from Kenya, Mali, Gambia, South Africa and Zambia obtained from GenBank and collected beyond the study period are indicated with a suffix gb. 
Clades containing African sequences were labelled to reflect genetic clusters observed on the continental (Africa) ON1 phylogeny—highlighted by 
grey vertical bars. African sequences are also indicated with tip labels. The most probable location of ancestral sequence at the branches leading to 
each African monophyletic clade is shown next to the nodes. Only ancestral locations with posterior probability support of > 70% were indicated
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introduction of multiple HMPV and RSV variants into 
Africa sub-regions from the global pool. South Africa 
and Zambia HMPV genotype patterns were charac-
terised by a unique circulation of HMPV A2.1 viruses, 
which were not detected in the other study sites. On the 
global phylogenies, HMPV and RSV African sequences 
were frequently placed into different monophyletic clades 
interspersed with global sequences, suggestive of multi-
ple sources of virus introduction into African countries 
and widespread movement of similar variants.
Previous studies of HMPV [47] and RSV [48] done 
in Argentina reveal the two viruses’ dispersal patterns 
occur both locally and globally. Similar findings have 
been reported for influenza viruses in Asia [49] and the 
USA [50]. Air travel has been shown to be the dominant 
determinant of influenza H3N2 and H1N1 viruses on 
the global scale [50, 51]. However, on smaller geographic 
scales, factors such demography, other forms of mobility, 
geographical proximity, etc. can be significant predic-
tors of spatial spread [48, 50]. The spatial diffusion path-
ways of HMPV and RSV revealed strong connections 
between countries in the same African sub-region and 
weak links between distant locations. Overall, the pat-
terns of spread of HMPV and RSV observed in this study 
may reflect underlying host mobility patterns. In particu-
lar, Africa experiences separate introduction of HMPV 
and RSV variants from the global pool influenced by 
human mobility patterns. Following a virus introduction, 
there is an establishment of a local epidemic in countries 
proximal to each other due to more interactions, associ-
ated with predominant migration between neighbouring 
countries [52], as a result of environmental and socio-
economic factors such as distribution of ethnic groups, 
colonial and regional trade ties [52]. Recent reports on 
the role of long-distance truck drivers from neighbour-
ing countries on the spread of SARS-CoV-2 in Uganda 
underscores these links between neighbouring countries 
[46]. We acknowledge that due to biased sampling, we 
did not assess possible introductions from unsampled 
locations. More analysis will be required to test the con-
tribution of human mobility and other potential predic-
tors on the spatial spread to explore the patterns further.
On the global scale, African HMPV and RSV 
sequences clustered with sequences sampled from 
different countries, suggesting multiple sources of 
introduction of HMPV and RSV variants into Africa. 
African sequences frequently clustered with sequences 
obtained from Canada, Peru, Malaysia, China, USA and 
Spain. These links only point to the potential sources of 
introductions of HMPV and RSV variants into Africa. 
Future analysis involving representative sampling will 
help to validate our inferences on the potential sources. 
Also, due to disproportionate sampling, it was also 
difficult to pinpoint the main hubs for evolution and 
selection of HMPV and RSV variants because the dis-
crete trait analysis is inherently biased by the sampling 
intensities of locations [53, 54]. To pinpoint the key 
source populations and subsequent sink populations, 
more representative sampling will be required globally.
Although our analysis was based on a modest sample 
size (HMPV n = 232 and RSV n = 842 sequences), this 
did not hinder our ability to assess sequence related-
ness and infer spatial-temporal spread of HMPV and 
RSV in Africa. Also, sequences were collected simul-
taneously over two years and allowed exploration of 
the spatial patterns to assess possible epidemiological 
linkages between Kenya, Mali, Gambia, South Africa, 
and Zambia. Conversely, we did not assess possible 
epidemiological links from unsampled locations in 
Africa. Future studies across different countries in dif-
ferent Africa sub-regions (East, West, South, Central 
and North) will be necessary for tracing transmission 
patterns of HMPV and RSV in Africa. Genetic clusters 
containing similar sequences, especially within-country 
clusters, will require whole-genome sequencing for 
increased resolution and detailed transmission studies.
We also analysed the clustering patterns of sequences 
by cases and controls. Sequences were found not to 
cluster by the individual’s sampled status. Additionally, 
we assessed the distribution of HMPV (group A and B) 
and RSV (group A and B) genetic variants among cases 
and controls. We found no statistically significant dif-
ference in the distribution of cases and controls among 
the subgroups for both HMPV (pr = 0.873) and RSV 
(pr = 0.733), Table 3. Our findings show no evidence for 
differences in disease severity between the subgroups 
for HMPV and RSV and concur with previous reports 
[5, 21, 23].
Conclusions
In conclusion, our study provides the first contempora-
neous HMPV and RSV sequences across 5 African coun-
tries, acting as a significant reference for future molecular 
epidemiological studies. HMPV and RSV molecular epi-
demiological patterns were consistent across the study 
locations in the continent. Multiple strains can co-circu-
late, and distinct strains can circulate in different Africa 
sub-regions at the same time. The occurrence of strong 
regional links suggested that local, tailored public health 
intervention measures should be considered. By com-
paring the strain epidemiology geographic patterns of 
HMPV and RSV across Africa, our study illuminates on 
the spread characteristics of two seasonally recurring res-
piratory viruses.
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